Alt image -https://content.stockstotrade.com/wp-content/uploads/2026/07/aehr-stock-rockets-after-earnings-beat-and-aggressive-fy27-guide.jpg
https://stockstotrade-nuxt-staging.stockstotrade-com-inc.workers.dev/

AEHR Stock Rockets After Earnings Beat And Aggressive FY27 Guide

TIM BOHENUPDATED JUL. 15, 2026, 10:05 AM ET
Reviewed by Ben Sturgilland Fact-checked by Ellis Hobbs

Aehr Test Systems surged as new wafer-level test orders fueled bullish sentiment, and stocks have been trading up by 42.34 percent

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading AEHR

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways AEHR Traders Need To Know

  • Fiscal Q4 revenue climbed 33% year over year to about $18.8M, with AEHR swinging from a loss to $0.11 EPS, far ahead of expectations for a slight loss.
  • Management’s fiscal 2027 revenue outlook of $130M–$150M, with 18%–22% net margins, crushes prior Street expectations of roughly $85M in sales.
  • Record quarterly bookings of $60.7M and an effective backlog around $100.6M give AEHR strong demand visibility across AI processors, silicon photonics, and power semiconductors.
  • Over $8M in fresh silicon carbide orders tied to Chinese EV programs and a top‑two global automaker deepen AEHR’s EV and automotive exposure.
  • A new FOX‑XP silicon photonics order anchors AEHR in the AI data‑center build‑out via high‑volume optical interconnect testing.

Candlestick Chart

Live Update At 10:02:56 EDT: On Wednesday, July 15, 2026 Aehr Test Systems stock [NASDAQ: AEHR] is trending up by 42.34%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

AEHR just put up the kind of quarter momentum traders look for. Fiscal Q4 revenue of about $18.8M rose 33% year over year and nudged past expectations. More important, Aehr Test Systems flipped from a loss to $0.11 in EPS, versus estimates for roughly -$0.01. That is a clear profitability inflection.

The chart backs up how the market is digesting this shift. AEHR closed at $72.01 on 2026/07/14, then exploded to $103.18 on 2026/07/15 after earnings and guidance. That’s a roughly 43% one‑day jump off the prior close, with an intraday high of $110.20. The 5‑minute tape shows a classic squeeze: AEHR ripped from the high $90s through $110 early, then cooled but held above $100 into the close. Dip buyers kept stepping in around $101–$103.

More Breaking News

Fundamentally, AEHR runs lean: almost no debt, an 11x current ratio, and strong cash. The flip side is a rich price‑to‑sales multiple near 59 and lumpy recent revenue trends. For traders, that combination—clean balance sheet, high growth expectations, and a stretched valuation—usually means big ranges and sharp reactions to every new headline.

Why Traders Are Watching AEHR After This Earnings Shock

AEHR is back in the hot‑momentum bucket after this fiscal Q4 and the fiscal 2027 guide. The company didn’t just beat; it rewrote the growth script. AEHR posted record bookings of $60.7M and reported an effective backlog near $100.6M, with another account citing $80.6M. Either way, that is a deep order book relative to its current revenue base. For traders, that backlog acts like fuel sitting under the chart.

The real spark is the fiscal 2027 outlook. Management is calling for $130M–$150M in revenue, which implies 160%–200% year‑over‑year growth versus the prior year, and they’re targeting 18%–22% non‑GAAP net margins. Street expectations sat closer to $85M. AEHR basically told the market its future runway is far longer and steeper than many models assumed. That kind of guide often forces analysts and big funds to re‑rate a name, and traders typically try to front‑run those upgrades.

What’s powering that confidence matters. AEHR is leaning into three secular waves: AI processors, silicon photonics, and power semiconductors like silicon carbide and GaN. Recent headlines show more than story. AEHR locked in over $8M of new silicon carbide wafer‑level burn‑in orders, including a major follow‑on from its lead SiC customer expanding EV capacity in China, plus a qualification order from one of the world’s top two automakers for next‑gen EVs. At the same time, AEHR secured a follow‑on FOX‑XP order from its lead silicon photonics customer to support high‑volume AI optical interconnect and hyperscale data‑center builds.

Traders watching EV names and AI‑linked semis know these are multi‑year themes. AEHR is positioning its burn‑in platforms right at the choke point where reliability testing meets volume ramp. That’s why the stock can swing double digits in a day: expectations are high, but so is the perceived opportunity.

Conclusion

AEHR is not trading like a sleepy small‑cap. In recent sessions, Aehr Test Systems ripped 14.6% to $77.80 on one day and dropped 15.5% to $71.38 on another. This week’s post‑earnings move from the low $70s to above $100 just reinforced that AEHR is a high‑beta battleground. Strong numbers and a bold fiscal 2027 guide have bulls pressing, but any hint of execution risk can trigger sharp profit‑taking.

Traders also need to keep the near‑term context in mind. Management has been clear that fiscal 2026 will likely be weaker than fiscal 2025, with the real ramp targeted for fiscal 2027 as AI, silicon photonics, and power‑semi demand accelerates. That gap between today’s revenue and tomorrow’s story is where volatility lives. Insider Form 4 filings have shown ownership changes, but with no detail on whether they were buys or sales, they don’t offer a clean read on sentiment.

For AEHR, everything now comes down to execution—turning that $60.7M in quarterly bookings and roughly $100M in effective backlog into consistent revenue while protecting those 18%–22% margin targets. Traders who follow Tim Sykes’s style know the drill here: “Patterns repeat, but the key is discipline—react to the price action, don’t predict it.” And in the same spirit of disciplined trading, as Tim Bohen, lead trainer with StocksToTrade says, “I never chase price. The best opportunities allow me to enter on my terms, not when I’m feeling pressured.” With AEHR, the fundamentals just lit the fuse; the chart will tell you if the momentum is real or fading. This analysis is for educational and research purposes only and is not investment advice.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.


The Game is Rigged

But Our AI-driven analysis Has Leveled the Playing Field

Sign up for access to institutional grade tools and insights – and join 10,000+ traders